U.S. flag

An official website of the United States government

Filters

See more specimen types...

Other countries

Results: 1 to 11 of 11

Tests names and labsConditionsGenes, analytes, and microbesMethods

Tyrosinemia type II (deletion/duplication analysis of TAT gene)

CGC Genetics Unilabs
Portugal
11
  • D Deletion/duplication analysis

IL31RA Gene Amyloidosis, primary localized cutaneous, type 2 NGS Genetic DNA Test

DNA Labs India
India
11
  • S Mutation scanning of the entire coding region

Amyloidosis, primary localized cutaneous, 2, 613955, Autosomal dominant; PLCA2 (Familial primary localized cutaneous amyloidosis) (IL31RA gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Hereditary amyloidosis (WES based NGS panel of 21 genes, including CNV analysis)

CGC Genetics Unilabs
Portugal
121
  • C Sequence analysis of the entire coding region

HEREDITARY AMYLOIDOSIS SYNDROME PANEL

Laboratorio de Genetica Clinica SL
Spain
122
  • E Sequence analysis of select exons

Familial Amyloidosis

Genologica Medica
Spain
4419
  • C Sequence analysis of the entire coding region

Genomic Unity® Custom Analysis

Variantyx, Inc.
United States
14054
  • D Deletion/duplication analysis
  • X Mutation scanning of select exons
  • C Sequence analysis of the entire coding region

Amyloidosis: Full gene sequencing panel

CEN4GEN Institute for Genomics and Molecular Diagnostics
Canada
88
  • C Sequence analysis of the entire coding region

AMYLOIDOSIS

Laboratorio de Genetica Clinica SL
Spain
510
  • C Sequence analysis of the entire coding region

IL31RA Single Gene

Fulgent Genetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Clinical Exome

Fulgent Genetics
United States
51284672
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 11 of 11

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.